Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.
Divrik
Rauf Taner
RT
Department of Urology, SB Tepecik Research and Training Hospital, Yenisehir, Izmir, Turkey. t.divrik@gmail.com
Sahin
Ali F
AF
Yildirim
Umit
U
Altok
Muammer
M
Zorlu
Ferruh
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015653:Cystectomy / Q000379:methods; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000601:surgery*; D009367:Neoplasm Staging; D011446:Prospective Studies; D012086:Reoperation; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D014521:Urethra; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*